|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 4/23/19 Procter & Gamble Co 10-Q 3/31/19 71:6.9M |
Document/Exhibit Description Pages Size
1: 10-Q FY 1819 Q3 Jfm 10-Q HTML 620K
2: EX-10.1 The Procter & Gamble Performance Stock Program HTML 109K
Summary
3: EX-31.1 Exhibit 31.1 Rule 13A-14(A)/15D-14(A) HTML 30K
Certification Chief Executive Officer
4: EX-31.2 Exhibit 31.2 Rule 13A-14(A)/15D-14(A) HTML 30K
Certification Chief Executive Officer
5: EX-32.1 Section 1350 Certification Chief Executive Officer HTML 25K
6: EX-32.2 Section 1350 Certification-Chief Financial Officer HTML 25K
13: R1 Document and Entity Information HTML 49K
14: R2 Consolidated Statements of Earnings HTML 79K
15: R3 Condolidated Statements of Comprehensive Income HTML 53K
16: R4 Consolidated Balance Sheets HTML 123K
17: R5 Consolidated Statements of Cash Flows HTML 102K
18: R6 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY HTML 100K
Consolidated Statements of Shareholders' Equity
QTD
19: R7 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY HTML 102K
Consolidated Statements of Shareholders' Equity
FYTD
20: R8 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY HTML 89K
Consolidated Statements of Shareholders' Equity PY
QTD
21: R9 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY HTML 89K
Consolidated Statements of Shareholders' Equity PY
YTD
22: R10 Basis of Presentation HTML 27K
23: R11 New Accounting Pronouncements and Policies HTML 40K
24: R12 Segment Information HTML 119K
25: R13 Goodwill and Other Intangible Assets HTML 69K
26: R14 Earnings Per Share HTML 75K
27: R15 Share-Based Compensation and Postretirement HTML 41K
Benefits
28: R16 Risk Management Activities and Fair Value HTML 112K
Measurements
29: R17 Accumulated Other Comprehensive Income (Loss) HTML 61K
30: R18 Restructuring Program HTML 70K
31: R19 Commitments and Contingencies HTML 29K
32: R20 Acquisition HTML 55K
33: R21 Segment Information (Tables) HTML 117K
34: R22 Goodwill and Other Intangible Assets (Tables) HTML 64K
35: R23 Earnings Per Share (Tables) HTML 74K
36: R24 Share-Based Compensation and Postretirement HTML 39K
Benefits (Tables)
37: R25 Risk Management Activities and Fair Value HTML 116K
Measurements (Tables)
38: R26 Accumulated Other Comprehensive Income (Loss) HTML 59K
(Tables)
39: R27 Restructuring Program (Tables) HTML 68K
40: R28 Acquisition - Allocation of Purchase Price HTML 38K
(Tables)
41: R29 Acquisition - Fair Value of Intangibles (Tables) HTML 36K
42: R30 Summary of Significant Accounting Policies - HTML 34K
Additional Information (Details)
43: R31 New Accounting Pronouncements and Policies - U.S. HTML 42K
Tax Reform (Details)
44: R32 Segment Information Segment Information - Sales HTML 51K
(Details)
45: R33 Segment Information (Details) HTML 51K
46: R34 Goodwill and Other Intangible Assets - Change in HTML 45K
the Net Carrying Amount of Goodwill by Global
Business Unit (Details)
47: R35 Goodwill and Other Intangible Assets - HTML 32K
Identifiable Intangible Assets (Details)
48: R36 Goodwill and Other Intangible Assets - Additional HTML 38K
Information (Details)
49: R37 Goodwill and Other Intangible Assets - Fair Value HTML 34K
Sensitivity (Details)
50: R38 Earnings Per Share (Details) HTML 69K
51: R39 Earnings Per Share - Antidilutive Securities HTML 29K
(Details)
52: R40 Share-Based Compensation and Postretirement HTML 37K
Benefits (Details)
53: R41 Risk Management Activities and Fair Value HTML 29K
Measurements - Assets and Liabilities Measured on
A Recurring Basis (Details)
54: R42 Risk Management Activities and Fair Value HTML 45K
Measurements - Schedule of Derivative Instruments
(Details)
55: R43 Risk Management Activities and Fair Value HTML 37K
Measurements - Derivative Instruments, Effect on
Other Comprehensive Income (Loss) (Details)
56: R44 Risk Management Activities and Fair Value HTML 28K
Measurements - Derivative Instruments, Effect on
Other Comprehensive Income (Loss) - Additional
Information (Details)
57: R45 Risk Management Activities and Fair Value HTML 32K
Measurements - Derivative Instruments Gain (Loss)
(Details)
58: R46 Risk Management Activities and Fair Value HTML 46K
Measurements - Additional Information (Details)
59: R47 Accumulated Other Comprehensive Income (Loss) - HTML 64K
Changes in Aoci and Reclassification Out of Aoci
(Details)
60: R48 Accumulated Other Comprehensive Income (Loss) - HTML 35K
Net of Tax Expense (Benefit) (Details)
61: R49 Restructuring Program - Additional Information HTML 38K
(Details)
62: R50 Restructuring Program - Restructuring Reserve by HTML 47K
Type of Costs (Details)
63: R51 Restructuring Program - Restructuring Costs Per HTML 42K
Segment (Details)
64: R52 Commitments and Contingencies - Additional HTML 29K
Information (Details)
65: R53 Acquisition - Allocation of Purchase Price HTML 59K
(Details)
66: R54 Acquisition Acquisition - Fair Value of HTML 45K
Intangibles (Details)
67: R55 Acquisition - Additional Information (Details) HTML 61K
68: R9999 Uncategorized Items - pg-20190331.xml HTML 89K
70: XML IDEA XML File -- Filing Summary XML 127K
69: EXCEL IDEA Workbook of Financial Reports XLSX 72K
7: EX-101.INS XBRL Instance -- pg-20190331 XML 2.06M
9: EX-101.CAL XBRL Calculations -- pg-20190331_cal XML 164K
10: EX-101.DEF XBRL Definitions -- pg-20190331_def XML 773K
11: EX-101.LAB XBRL Labels -- pg-20190331_lab XML 1.18M
12: EX-101.PRE XBRL Presentations -- pg-20190331_pre XML 915K
8: EX-101.SCH XBRL Schema -- pg-20190331 XSD 131K
71: ZIP XBRL Zipped Folder -- 0000080424-19-000031-xbrl Zip 191K
| Exhibit |
(1) | I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company; |
(2) | Based on my knowledge,
this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
(3) | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
(4) | The
registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(5) | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/
DAVID S. TAYLOR |
Chairman of the Board, President and Chief Executive Officer |
Date |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/23/19 | 8-K | ||
| For Period end: | 3/31/19 | |||
| List all Filings | ||||